Bonora, B. M.
Russo, G.
Leonetti, F.
Strazzabosco, M.
Nollino, L.
Aimaretti, G.
Giaccari, A.
Broglio, F.
Consoli, A.
Avogaro, A.
Fadini, G. P. http://orcid.org/0000-0002-6510-2097
,
Funding for this research was provided by:
SocietĂ Italiana di Diabetologia
UniversitĂ degli Studi di Padova
Article History
Received: 15 November 2023
Accepted: 11 January 2024
First Online: 18 February 2024
Declarations
:
: BMB received lecture or advisory board fees from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Mundipharma, Novartis, Novo Nordisk and Sanofi. GR is on the advisory board and does consultancy and lectures for Novo Nordisk, Astra Zeneca, Sanofi, Boehringer, Lilly, Mundipharma, and Sanchio. AG received lecture fees from Novo Nordisk. AC received grants from Astra Zeneca, Lilly, Novo-Nordisk. He also received speaker fees, and provided advisory board services for Abbott, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Lilly, Merck Sharp & Dhome, Menarini, Novo-Nordisk, Sanofi, Sigma-Tau. AA received research grants and lecture or advisory board fees from MSD, AstraZeneca, Novartis, Boehringer Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier and Takeda. GPF received grants, lecture or advisory board fees from Abbott, AstraZeneca, Boehringer, Lilly, Novo Nordisk, Novartis, Sanofi, Servier. FL, MS, LN, GA, FB have nothing to disclose
: The study was first approved by the Ethical Committee of the coordinating center (University Hospital of Chieti-Pescara, prot. n. 09 dated 19/05/2022) and by the Ethical Committees of all participating Centers.
: The study was conducted according to the principles of the Declaration of Helsinki.
: In agreement with national regulation on retrospective studies on anonymized patients’ data, the need for informed consent was waived.